Solugen is a biotechnology company that produces chemicals through engineered biology rather than traditional petrochemical processes. The company uses synthetic biology and enzymatic processes to manufacture industrial chemicals, with a focus on creating more sustainable and environmentally friendly alternatives to conventional chemical production methods.
Founded to address the environmental impact of the chemical industry, Solugen operates in the industrial biotechnology and sustainable manufacturing sector. The company has raised venture funding to scale its bio-based chemical production platform and has attracted attention from investors focused on cleantech and industrial transformation. Solugen's approach represents part of a broader shift toward biotechnology-enabled manufacturing, aiming to reduce the chemical industry's reliance on fossil fuels while producing high-quality industrial chemicals for various applications.
Solugen has received investment from 4 venture capital firms.
Biotechnology company producing industrial chemicals through engineered biology and sustainable manufacturing processes.
Solugen has received investment from 8VC, Audacious Ventures, Fifty Years, Wireframe Ventures. These venture capital firms and investors provide both capital and strategic support.
Solugen operates in the Biotech sector. Biotechnology company producing industrial chemicals through engineered biology and sustainable manufacturing processes.
